Fenugreek safety studies
Pro Research Analysisby 
Searched over 200M research papers
Fenugreek Safety Studies: Toxicological Evaluation and Human Data
Acute and Subchronic Toxicity of Fenugreek Extracts in Animal Studies
Multiple studies have evaluated the safety of fenugreek seed extracts in animal models. Acute and subchronic toxicity studies using standardized saponin-rich and glycoside-based fenugreek extracts in rats found no significant toxic effects, even at high doses (up to 2000–2500 mg/kg body weight) over periods up to 90 days. These studies reported no mortality, no adverse clinical or behavioral changes, and no significant alterations in organ weights, hematological, or biochemical parameters. Histopathological examinations also revealed no treatment-related changes, and the extracts showed no mutagenic potential in standard in vitro tests. The no observed-adverse-effect level (NOAEL) was established at 1000 mg/kg/day for most extracts, with some gender differences noted in one study (1000 mg/kg for males, 500 mg/kg for females) Sureshkumar2018Deshpande2016.
Organ-Specific Safety: Liver, Kidney, and Heart
Animal experiments assessing the effects of methanolic fenugreek seed extracts on hepatic, renal, and cardiac parameters found no significant adverse effects. After 45 days of administration at various doses, there were no significant changes in liver enzymes, kidney function markers, or cardiac enzymes compared to controls, supporting the safety of fenugreek for these organs .
Dose-Dependent Effects and Tolerability
Dose-dependent studies in rats showed that fenugreek is generally well tolerated at moderate doses (up to 2.5% of diet by weight). At very high doses (12.3% of diet), some animals experienced reduced appetite and diarrhea, but no other significant adverse effects were observed at lower doses . Short-term studies (90 days) in rats also found no significant differences in food intake, body weight, or feed efficiency, and no toxicological changes in blood or tissue analysis, even at high dietary levels (up to 20%) .
Human Clinical Data and Systematic Reviews
Systematic reviews and meta-analyses of randomized controlled trials in humans, including people with type 2 diabetes and prediabetes, found that fenugreek supplementation significantly improved glycemic control and lipid profiles. Importantly, these studies reported no evidence of hepatic or renal toxicity and no severe adverse events. The most common side effects were mild gastrointestinal symptoms Kim2023Gong2016. A clinical trial in postmenopausal women using a standardized fenugreek extract for 90 days also found no safety concerns based on hematological and biochemical parameters .
Comprehensive Toxicological Reviews
A systematic review using the ToxRTool identified 17 high-quality, guideline-compliant animal studies that consistently demonstrated a broad margin of safety for standardized fenugreek seed extracts. These studies form a reliable basis for toxicological risk assessment .
Special Considerations and Potential Risks
While most studies support the safety of fenugreek, some reviews highlight potential risks. Fenugreek may have teratogenic effects and anti-fertility properties in animal models, suggesting it should not be used during pregnancy. There is also a risk of allergic reactions in individuals sensitive to peanuts or chickpeas, and possible neurodevelopmental effects have been suggested, though these require further investigation .
Conclusion
Overall, standardized fenugreek seed extracts have demonstrated a broad margin of safety in both animal and human studies, with no significant toxicity observed at commonly used doses. Mild gastrointestinal symptoms are the most frequently reported side effects. However, caution is advised for pregnant women and individuals with legume allergies. High-quality toxicological studies support the safe use of fenugreek in food supplements and as a complementary therapy, but further research is warranted to clarify rare or long-term risks.
Sources and full results
Most relevant research papers on this topic
The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Fenugreek effectively improves overall glycemic control parameters and lipid profile in type 2 diabetes and prediabetes patients without causing severe adverse events.
Dose-dependent effects, safety and tolerability of fenugreek in diet-induced metabolic disorders in rats
Fenugreek effectively reduces liver triglyceride and total cholesterol levels by increasing lipid excretion in feces, with a safe and tolerable dose of around 2.50% (w/w) in diet-induced metabolic disorders in rats.
Toxicological properties of fenugreek (Trigonella foenum graecum).
Fenugreek consumption may cause serious toxicological side effects, including teratogenic effects, anti-fertility, and neurodevelopmental issues.
DOI